VCEL
Vericel Corporation NASDAQ Listed Feb 4, 1997$40.10
+2.48%
vs $39.13
Mkt Cap $2.0B
52w Low $28.95
76.3% of range
52w High $43.57
50d MA $35.26
200d MA $35.44
P/E (TTM)
125.3x
EV/EBITDA
64.4x
P/B
5.7x
Debt/Equity
0.3x
ROE
4.7%
P/FCF
84.4x
RSI (14)
80.60
ATR (14)
$1.62
Beta
1.21
50d MA
$35.26
200d MA
$35.44
Avg Volume
668.7K
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
64 Sidney Street · Cambridge, MA 02139 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 36.78 | +10.1% | -4.5% | -4.8% | -1.6% | +0.1% | -0.3% | — |
| Feb 26, 2026 | AMC | 0.45 | 0.45 | +0.0% | 37.68 | -2.7% | -5.3% | -0.9% | -2.7% | +1.7% | -2.7% | — |
| Nov 6, 2025 | AMC | -0.02 | 0.10 | +600.0% | 38.75 | +0.9% | +0.5% | +0.1% | +5.3% | -1.5% | -1.5% | — |
| Jul 31, 2025 | AMC | -0.04 | -0.01 | +75.0% | 34.94 | -1.6% | +2.0% | +5.5% | -2.0% | -1.4% | -0.4% | — |
| May 8, 2025 | AMC | -0.09 | -0.23 | -155.6% | 41.87 | -0.2% | -0.3% | +2.2% | +2.3% | -3.1% | -1.9% | — |
| Feb 27, 2025 | AMC | 0.31 | 0.38 | +22.6% | 49.62 | +0.0% | +3.4% | -3.5% | +3.3% | +0.8% | -5.4% | — |
| Nov 7, 2024 | AMC | -0.05 | -0.02 | +60.0% | 50.03 | -1.0% | +7.9% | +5.1% | -1.6% | -0.8% | -4.9% | — |
| Aug 1, 2024 | AMC | -0.10 | -0.10 | +0.0% | 47.52 | -1.2% | +0.2% | -3.7% | +1.9% | -3.1% | +2.1% | — |
| May 8, 2024 | AMC | -0.11 | -0.08 | +27.3% | 47.69 | +0.3% | +2.0% | -1.1% | +0.9% | +0.0% | +1.8% | — |
| Feb 29, 2024 | AMC | 0.17 | 0.26 | +52.9% | 45.68 | +1.6% | -2.1% | +0.1% | -0.7% | +1.6% | -0.8% | — |
| Nov 8, 2023 | AMC | -0.13 | -0.08 | +38.5% | 35.27 | +0.3% | -8.1% | +4.6% | +0.1% | +8.2% | -1.9% | — |
| Aug 2, 2023 | AMC | -0.13 | -0.11 | +15.4% | 34.63 | +0.9% | -7.7% | +0.1% | -0.3% | +2.8% | -2.0% | — |
| May 10, 2023 | AMC | -0.13 | -0.16 | -23.1% | 34.19 | +0.7% | -3.5% | -0.6% | +2.9% | -2.0% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | Truist | Maintains | Buy → Buy | — | $35.14 | $34.89 | -0.7% | +0.7% | -4.5% | +5.7% | +0.4% | -6.0% |
| Feb 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $37.68 | $36.66 | -2.7% | -5.3% | -0.9% | -2.7% | +1.7% | -2.7% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $36.40 | $36.40 | +0.0% | -0.7% | -0.3% | +3.7% | +0.0% | +0.5% |
| Nov 10 | Truist | Maintains | Buy → Buy | — | $38.94 | $39.71 | +2.0% | +0.1% | +5.3% | -1.5% | -1.5% | +0.1% |
| Oct 15 | Truist | Maintains | Buy → Buy | — | $34.64 | $34.23 | -1.2% | -3.0% | +3.5% | +1.6% | +2.0% | +1.2% |
| Sep 17 | BTIG | Downgrade | Buy → Neutral | — | $33.23 | $31.85 | -4.2% | -9.7% | +6.1% | -0.5% | +0.4% | -1.9% |
| Aug 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $34.94 | $34.38 | -1.6% | +2.0% | +5.5% | -2.0% | -1.4% | -0.4% |
| Jun 16 | Stephens & Co. | Maintains | Overweight → Overweight | — | $42.67 | $43.03 | +0.8% | -2.5% | -0.2% | +0.7% | +0.6% | -0.5% |
| May 22 | Stephens & Co. | Maintains | Overweight → Overweight | — | $41.07 | $40.74 | -0.8% | +0.8% | -1.1% | +2.8% | +0.1% | -1.8% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $41.90 | $41.33 | -1.4% | -1.6% | -0.0% | +1.9% | -2.9% | +1.0% |
| Mar 3 | Truist | Maintains | Buy → Buy | — | $51.29 | $51.20 | -0.2% | -3.5% | +3.3% | +0.8% | -5.4% | +1.6% |
| Feb 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $49.62 | $49.63 | +0.0% | +3.4% | -3.5% | +3.3% | +0.8% | -5.4% |
| Feb 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $58.54 | $58.25 | -0.5% | +0.9% | +0.6% | +4.0% | -3.4% | -2.3% |
| Jan 15 | Stephens & Co. | Maintains | Overweight → Overweight | — | $58.67 | $55.09 | -6.1% | -1.9% | -2.1% | +4.8% | +0.8% | -1.7% |
| Jan 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $58.67 | $55.09 | -6.1% | -1.9% | -2.1% | +4.8% | +0.8% | -1.7% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $56.69 | $57.07 | +0.7% | -0.8% | -2.3% | +2.8% | +1.0% | +0.5% |
| Nov 26 | BTIG | Maintains | Buy → Buy | — | $58.62 | $58.40 | -0.4% | +0.2% | -1.7% | +0.7% | +1.0% | -0.9% |
| Nov 19 | Canaccord Genuity | Maintains | Buy → Buy | — | $52.89 | $52.68 | -0.4% | +5.6% | +2.6% | -1.0% | +4.2% | -0.8% |
| Nov 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $50.03 | $49.54 | -1.0% | +7.9% | +5.1% | -1.6% | -0.8% | -4.9% |
| Aug 27 | TD Cowen | Maintains | Buy → Buy | — | $49.94 | $49.85 | -0.2% | +7.2% | -1.8% | -1.9% | +0.2% | -5.1% |
| Aug 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $47.52 | $46.97 | -1.2% | +0.2% | -3.7% | +1.9% | -3.1% | +2.1% |
| Aug 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $47.52 | $46.97 | -1.2% | +0.2% | -3.7% | +1.9% | -3.1% | +2.1% |
| Jul 16 | Truist | Maintains | Buy → Buy | — | $49.85 | $50.66 | +1.6% | +4.8% | -1.0% | -0.9% | -2.2% | +2.9% |
| Jul 15 | BTIG | Maintains | Buy → Buy | — | $48.50 | $48.63 | +0.3% | +2.8% | +4.8% | -1.0% | -0.9% | -2.2% |
| May 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $47.69 | $47.83 | +0.3% | +2.0% | -1.1% | +0.9% | +0.0% | +1.8% |
| Mar 26 | Truist | Maintains | Buy → Buy | — | $47.94 | $48.13 | +0.4% | +3.4% | +5.6% | -0.6% | +1.7% | -3.1% |
| Mar 1 | Truist | Maintains | Buy → Buy | — | $45.68 | $46.43 | +1.6% | -2.1% | +0.1% | -0.7% | +1.6% | -0.8% |
| Mar 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $45.68 | $46.43 | +1.6% | -2.1% | +0.1% | -0.7% | +1.6% | -0.8% |
| Jan 25 | Truist | Upgrade | Hold → Buy | — | $40.82 | $43.41 | +6.3% | +4.4% | +0.0% | +4.6% | -0.7% | -2.9% |
| Jan 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $38.24 | $38.39 | +0.4% | +2.5% | -3.5% | +3.5% | +1.3% | +5.9% |
| Nov 9 | Truist | Maintains | Hold → Hold | — | $35.27 | $35.39 | +0.3% | -8.1% | +4.6% | +0.1% | +8.2% | -1.9% |
| Sep 21 | Truist | Maintains | Hold → Hold | — | $32.52 | $33.26 | +2.3% | +5.1% | -0.6% | +0.0% | -1.5% | +6.0% |
| Sep 21 | Stephens & Co. | Maintains | Overweight → Overweight | — | $32.52 | $33.26 | +2.3% | +5.1% | -0.6% | +0.0% | -1.5% | +6.0% |
| Sep 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.52 | $33.26 | +2.3% | +5.1% | -0.6% | +0.0% | -1.5% | +6.0% |
| Aug 8 | BTIG | Upgrade | Neutral → Buy | — | $31.90 | $33.22 | +4.1% | +2.8% | -2.0% | -0.9% | -0.6% | +1.5% |
| Aug 3 | Truist | Maintains | Hold → Hold | — | $34.63 | $34.95 | +0.9% | -7.7% | +0.1% | -0.3% | +2.8% | -2.0% |
| Aug 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $34.63 | $34.95 | +0.9% | -7.7% | +0.1% | -0.3% | +2.8% | -2.0% |
| Jul 19 | Truist | Maintains | Hold → Hold | — | $38.87 | $39.06 | +0.5% | +1.0% | -2.4% | +1.1% | -0.9% | -2.6% |
| May 11 | Truist | Maintains | Hold → Hold | — | $34.19 | $34.44 | +0.7% | -3.5% | -0.6% | +2.9% | -2.0% | -0.6% |
| May 11 | Stephens & Co. | Maintains | Overweight → Overweight | — | $34.19 | $34.44 | +0.7% | -3.5% | -0.6% | +2.9% | -2.0% | -0.6% |
| Feb 27 | Truist | Maintains | Hold → Hold | — | $30.50 | $30.82 | +1.0% | +0.6% | -0.9% | -1.4% | +0.8% | +3.6% |
| Jan 31 | Truist | Maintains | Hold → Hold | — | $27.03 | $27.03 | +0.0% | +1.6% | +3.3% | +10.5% | -0.9% | -1.5% |
| Jan 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $27.85 | $27.83 | -0.1% | +2.4% | -5.3% | +1.6% | +3.3% | +10.5% |
| Jan 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.34 | $26.60 | +1.0% | -4.6% | +1.5% | -4.1% | -2.4% | -0.1% |
| Dec 20 | Truist | Maintains | Hold → Hold | — | $22.84 | $22.89 | +0.2% | +4.5% | +3.5% | -1.1% | -2.4% | -1.2% |
| Nov 10 | BTIG | Downgrade | Buy → Neutral | — | $17.65 | $17.39 | -1.5% | +27.0% | +6.2% | -3.0% | +0.8% | -3.7% |
| Nov 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $17.65 | $17.39 | -1.5% | +27.0% | +6.2% | -3.0% | +0.8% | -3.7% |
| Jul 18 | BTIG | Maintains | Buy → Buy | — | $27.54 | $27.74 | +0.7% | -1.1% | +3.7% | -0.4% | +1.8% | -1.5% |
| Feb 25 | SVB Leerink | Maintains | Outperform → Outperform | — | $38.88 | $38.60 | -0.7% | +0.9% | +5.1% | -1.3% | +6.5% | -5.8% |
| Dec 21 | Truist | Maintains | Buy → Buy | — | $38.30 | $38.39 | +0.2% | +4.0% | +1.6% | +2.9% | +0.8% | -3.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 4,375 | $35.00 | $153K | 75,753 | +1.71% | +3.18% |
| May 13, 2026 | MCLAUGHLIN KEVIN F | — | Sell | 3,500 | $32.83 | $115K | 18,300 | +5.57% | -1.19% |
| May 11, 2026 | Wotton Paul K | — | Sell | 7,500 | $32.64 | $245K | 18,802 | +0.91% | +2.64% |
| May 11, 2026 | Wotton Paul K | — | Sell | 2,500 | $33.05 | $83K | 26,302 | +0.91% | +2.64% |
| May 7, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 5,000 | $40.50 | $202K | 21,009 | -1.61% | -0.33% |
| May 7, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,422 | $40.50 | $58K | 1,118 | -1.61% | -0.33% |
| May 6, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,433 | $38.00 | $130K | 2,540 | -1.61% | -0.33% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Soleus Capital Management, L.p. | 2,549,079 | $82M | Added | Mar 2026 |
| 2 | Conestoga Capital Advisors, Llc | 2,463,312 | $79M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 2,230,756 | $72M | New | Mar 2026 |
| 4 | William Blair Investment Management, Llc | 1,832,709 | $59M | Reduced | Mar 2026 |
| 5 | Bnp Paribas Asset Management Holding S.a. | 1,723,572 | $55M | Added | Mar 2026 |
| 6 | Geneva Capital Management Llc | 1,646,818 | $53M | Reduced | Mar 2026 |
| 7 | Morgan Stanley | 1,395,446 | $50M | Added | Dec 2025 |
| 8 | Congress Asset Management Co | 1,506,918 | $48M | Reduced | Mar 2026 |
| 9 | Bank Of America Corp /de/ | 1,098,771 | $35M | Added | Mar 2026 |
| 10 | Vanguard Portfolio Management Llc | 991,626 | $32M | New | Mar 2026 |
| 11 | Royal Bank Of Canada | 882,162 | $28M | Reduced | Mar 2026 |
| 12 | Champlain Investment Partners, Llc | 815,173 | $26M | Reduced | Mar 2026 |
| 13 | Allspring Global Investments Holdings, Llc | 678,003 | $22M | Reduced | Mar 2026 |
| 14 | Aberdeen Group Plc | 684,125 | $22M | Added | Mar 2026 |
| 15 | Brown Capital Management Llc | 592,494 | $19M | Reduced | Mar 2026 |
| 16 | Northern Trust Corp | 542,755 | $17M | Added | Mar 2026 |
| 17 | Two Sigma Investments, Lp | 485,012 | $16M | Added | Mar 2026 |
| 18 | Frontier Capital Management Co Llc | 413,705 | $15M | Added | Dec 2025 |
| 19 | Divisadero Street Capital Management, Lp | 422,178 | $14M | Added | Mar 2026 |
| 20 | Raymond James Financial Inc | 422,333 | $13M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.05B
Enterprise Value
$1.95B
P/E (TTM)
125.31x
Forward P/E
92.29x
PEG Ratio
1.93x
P/B
5.72x
P/S
7.56x
P/FCF
84.37x
EV/EBITDA
64.39x
Shares Out
52.1M
Financials (TTM)
Revenue
$276.3M
Net Income
$16.5M
EBITDA
$30.3M
Free Cash Flow
$24.7M
Op Cash Flow
$51.9M
EPS Basic
$0.33
EPS Diluted
$0.32
EPS Forward
$0.43
Gross Margin
74.4%
Op Margin
4.0%
Net Margin
6.0%
Balance Sheet
Total Assets
$488.0M
Total Liab.
$133.3M
Total Equity
$354.6M
Cash
$137.5M
LT Debt
$0
Book Value/Sh
$7.01
Debt/Equity
0.28x
Current Ratio
5.03
Quick Ratio
4.68
Returns & Growth
ROE
4.7%
ROA
3.4%
ROIC
2.3%
Rev Growth YoY
+16.4%
EPS Growth YoY
+57.1%
Price Returns
2W
+0.6%
1M
-4.0%
3M
-6.6%
6M
-17.2%
12M
-19.3%
Technicals
52W High
$43.57
52W Low
$28.95
50d MA
$35.26
200d MA
$35.44
RSI (14)
80.60
ATR (14)
$1.62
Beta
1.21
Avg Volume
669K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$44.00
High
$46.00
Low
$42.00
Median
$44.00
Data updated apr 27, 2026 7:24am
· Source: financialmodelingprep.com